FDA

The U.S. Food and Drug Administration (FDA), an agency within the U.S. Department of Health and Human Services, promotes and protects the public health by, among other things, assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

www.fda.gov

FDA RSS Channel

Filters
List of articles in category FDA
Title Published Date
FDA takes new steps to adopt more modern technologies for improving the security of the drug supply chain 14 February 2019
FDA takes action against 17 companies for illegally selling products claiming to treat Alzheimer's disease 11 February 2019
FDA approves first therapy for the treatment of adult patients with a rare blood clotting disorder 06 February 2019
FDA approves first generic Advair Diskus 31 January 2019
FDA approves first treatment for rare blood disease 21 December 2018
FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs 10 December 2018
FDA approves first treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder 30 November 2018
FDA approves new treatment for patients with acute myeloid leukemia 22 November 2018
FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilot 19 November 2018
FDA highlights record-breaking number of generic drug approvals in October 09 November 2018
FDA approves new drug to treat influenza 26 October 2018
FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs 23 October 2018
FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old 08 October 2018
FDA approves first treatment for advanced form of the second most common skin cancer 28 September 2018
FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases 24 September 2018
FDA approves new kind of treatment for hairy cell leukemia 13 September 2018
FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease 10 August 2018
FDA approves treatment for two rare types of non-Hodgkin lymphoma 08 August 2018
FDA approves first targeted treatment for patients with relapsed or refractory acute myeloid leukemia who have a certain genetic mutation 20 July 2018
FDA approves first cancer drug through new oncology review pilot that enables greater development efficiency 18 July 2018

Business & Industry

Research & Development

Conferences & Events

Regulatory Affairs